Plain-English translation of NCT06958627 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether using an intelligent patient management system — basically a smartphone-based support tool — helps women with HER2-positive breast cancer take their medication () as prescribed. The study will compare this new smart system to the traditional way patients manage their medications on their own. Researchers want to see if having this digital support can make a real difference in how consistently people take their treatment.
Many cancer patients struggle to take their medications exactly as prescribed, which can affect how well the treatment works. This trial is exploring whether a smartphone-based support system can help patients stay on track with this medication better than the current standard approach.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either use the new smartphone-based support system or follow the traditional approach to managing your medication. Those in the smartphone group will receive reminders and support through an app or messaging system to help you remember to take your medication on schedule. You'll likely have regular check-ins with the research team at multiple medical centers to track how well the system is working and how you're doing on your treatment.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China